Related Experiment Video
Updated: Aug 8, 2026
Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
[Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma]
Insights
Flow cytometry effectively identifies B-cell non-Hodgkin's lymphoma by detecting surface immunoglobulin (S-Ig) light chains. This rapid method confirms diagnosis in 84% of B-cell lymphoma cases, aiding in accurate patient management.
Area of Science:
- Hematology
- Immunology
- Oncology
Context:
- B-cell non-Hodgkin's lymphoma (NHL) diagnosis relies on immunophenotyping.
- Distinguishing B-cell lineage requires identifying specific cell surface markers.
- Accurate diagnosis is crucial for effective treatment strategies.
Purpose:
- To evaluate the diagnostic utility of flow cytometry for B-cell NHL.
- To analyze the expression of surface immunoglobulin (S-Ig) light chains and monoclonal antibodies (MoAbs).
- To correlate immunophenotypic findings with lymphoma subtypes.
Summary:
- Flow cytometry detected monoclonal S-Ig light chain expression in 84% of B-cell lymphoma patients.
- Specific antigen expression (CD10, CD11b) varied with lymphoma histology (e.g., diffuse large cell lymphoma).
- Immunohistochemistry confirmed monoclonal cytoplasmic immunoglobulin in rare polyclonal S-Ig cases.
Impact:
- Flow cytometry offers a rapid and objective method for confirming B-cell NHL diagnoses.
- This technique aids in precise immunological classification of lymphoma subtypes.
- Improved diagnostic accuracy can lead to more tailored therapeutic approaches.
Abstract:
The objective of this study is to demonstrate the diagnostic usefulness of flow cytometric analysis of surface immunoglobulin (S-Ig) light chains and monoclonal antibodies (MoAbs) in B-cell non-Hodgkin's lymphoma. For this purpose, the biopsied specimen (lymph nodes, tonsils, and spleens etc) cell suspensions from 44 patients were studied to detect the expression of S-Ig and several antigens recognized by MoAbs. A tumor was considered B-lineage if expression of pan B antigens and/or monoclonal light chains (S-Ig and/or cytoplasmic Ig) was detected in the absence of pan T antigens. Monoclonal expression of S-Ig light chain was detectable in 37 of 44 (84%) patients with B-cell lymphoma. In two of three cases having polyclonal S-Ig light chain, monoclonal C-Ig light chain was detected in large cells on paraffin-embedded tissues with immunohistochemical technique. Pan B antigens were strongly positive in four cases with negative S-Ig light chain. In diffuse large cell lymphoma, expression of CD11b was restricted to non-cleaved cell type (DLN). CD10 was favorably expressed by non-cleaved cell type and to a lesser extent, by immunoblastic histology (LI), but was not detected on cases with cleaved cell type (DLC). Furthermore, relatively uniform expression of S-IgM was seen in DLC subgroup, and on the contrary, heterogenous S-Ig was shown in other histology groups (DLN, LI). Flow cytometry provides a rapid, objective technology to confirm the immunological diagnosis of B-cell non-Hodgkin's lymphoma.
